The private versus public contribution to the biomedical literature during the COVID-19, Ebola, H1N1, and Zika public health emergencies

<h4>Background</h4> The private versus public contribution to developing new health knowledge and interventions is deeply contentious. Proponents of commercial innovation highlight its role in late-stage clinical trials, regulatory approval, and widespread distribution. Proponents of pub...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Reed F. Beall, Javad Moradpour, Aidan Hollis
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/bbdf4ba2572e407d8c7e6934c1427eef
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!